Ethic Inc. boosted its holdings in Xylem Inc. (NYSE:XYL - Free Report) by 16.5% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 84,528 shares of the industrial products company's stock after buying an additional 12,001 shares during the period. Ethic Inc.'s holdings in Xylem were worth $8,560,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. BlackRock Inc. purchased a new position in shares of Xylem in the second quarter valued at about $2,959,730,000. State Street Corp boosted its stake in shares of Xylem by 2.4% in the second quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock worth $1,352,874,000 after acquiring an additional 270,972 shares during the period. XXEC Inc. bought a new position in shares of Xylem in the second quarter worth about $850,841,000. Royal Bank of Canada grew its position in shares of Xylem by 1.1% during the first quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company's stock worth $569,207,000 after purchasing an additional 53,210 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Xylem during the second quarter worth about $552,313,000. 87.96% of the stock is owned by institutional investors.
Insider Transactions at Xylem
In other news, Director D Koch acquired 11,000 shares of Xylem stock in a transaction on Thursday, October 29th. The shares were acquired at an average price of $89.60 per share, with a total value of $985,600.00. Following the purchase, the director directly owned 12,247 shares in the company, valued at $1,097,331.20. The trade was a 882.12% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.32% of the stock is currently owned by insiders.
Xylem Trading Up 0.0%
Shares of Xylem stock opened at $97.88 on Monday. The firm has a market cap of $22.45 billion, a price-to-earnings ratio of 21.65, a PEG ratio of 1.63 and a beta of 1.01. The business has a 50-day moving average price of $103.56 and a 200-day moving average price of $116.48. The company has a quick ratio of 1.02, a current ratio of 1.39 and a debt-to-equity ratio of 0.23. Xylem Inc. has a twelve month low of $87.40 and a twelve month high of $152.15.
Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.45 by ($0.01). The firm had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. Xylem had a return on equity of 12.06% and a net margin of 11.94%. The company's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period last year, the firm posted $1.37 earnings per share. Equities research analysts anticipate that Xylem Inc. will post 5.45 EPS for the current fiscal year.
Xylem Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.8%. The ex-dividend date was Thursday, August 27th. Xylem's dividend payout ratio (DPR) is currently 38.05%.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the company. The Goldman Sachs Group decreased their target price on Xylem from $160.00 to $138.00 and set a "buy" rating on the stock in a research note on Wednesday, October 28th. Robert W. Baird set a $123.00 price target on Xylem in a research note on Wednesday, October 28th. JPMorgan Chase & Co. lowered shares of Xylem from an "overweight" rating to a "neutral" rating and cut their price objective for the company from $118.00 to $90.00 in a report on Wednesday, October 28th. Stifel Nicolaus reduced their price objective on shares of Xylem from $141.00 to $114.00 and set a "buy" rating on the stock in a research report on Wednesday, October 28th. Finally, UBS Group reduced their price objective on shares of Xylem from $112.00 to $99.00 and set a "neutral" rating on the stock in a research report on Thursday, October 29th. Nine investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $121.31.
Get Our Latest Stock Report on XYL
Xylem Company Profile
(
Free Report)
Xylem Inc is a water technology company that develops equipment, software and services for managing water and wastewater. Its offerings include pumps and treatment systems, water-quality testing and analysis, smart meters, monitoring and control technologies, and services for detecting leaks and maintaining water infrastructure.
The company serves water and wastewater utilities, industrial and commercial customers, and residential markets. Its technologies support the movement, treatment, testing and efficient use of water across municipal and industrial systems.
Xylem was established in 2011 when it became an independent company following its spin-off from ITT Corporation.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.